Published in Prev Med on March 01, 1992
Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level. J Clin Invest (1994) 1.72
Two siblings with familial chylomicronemia syndrome: disease course and effectiveness of early treatment. Case Rep Med (2010) 0.75
The C-terminal domain of RNA polymerase II couples mRNA processing to transcription. Nature (1997) 8.86
Direct and selective binding of an acidic transcriptional activation domain to the TATA-box factor TFIID. Nature (1990) 7.11
Arabinose C protein: regulation of the arabinose operon in vitro. Nat New Biol (1971) 4.99
Opposing effects of Ctk1 kinase and Fcp1 phosphatase at Ser 2 of the RNA polymerase II C-terminal domain. Genes Dev (2001) 4.64
Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis. The Bogalusa Heart Study. N Engl J Med (1986) 4.26
Reduced binding of TFIID to transcriptionally compromised mutants of VP16. Nature (1991) 3.98
Three functional classes of transcriptional activation domain. Mol Cell Biol (1996) 3.62
Passive smoking on commercial airline flights. JAMA (1989) 3.24
Isolation of three proteins that bind to mammalian RNA polymerase II. J Biol Chem (1985) 3.11
The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: a review of randomized controlled trials. Prog Cardiovasc Dis (1987) 2.77
NMR structure of the bacteriophage lambda N peptide/boxB RNA complex: recognition of a GNRA fold by an arginine-rich motif. Cell (1998) 2.73
Two forms of simian-virus-40-specific T-antigen in abortive and lytic infection. Proc Natl Acad Sci U S A (1976) 2.67
Interaction of the sigma factor and the nusA gene protein of E. coli with RNA polymerase in the initiation-termination cycle of transcription. Cell (1981) 2.57
Activation of the alternate complement pathway by peptidoglycan from streptococcal cell wall. Infect Immun (1978) 2.57
Dual control of arabinose genes on transducing phage lambda-dara. J Mol Biol (1971) 2.50
Cholesterol and heart disease in older persons and women. Review of an NHLBI workshop. Ann Epidemiol (1994) 2.50
Structure and associated DNA-helicase activity of a general transcription initiation factor that binds to RNA polymerase II. Nature (1989) 2.47
The transactivator proteins VP16 and GAL4 bind replication factor A. Cell (1993) 2.32
The small subunit of transcription factor IIF recruits RNA polymerase II into the preinitiation complex. Proc Natl Acad Sci U S A (1991) 2.29
Body height and body mass as determinants of basal blood pressure in children--The Bogalusa Heart Study. Am J Epidemiol (1977) 2.27
The acute myeloid leukemia-associated protein, DEK, forms a splicing-dependent interaction with exon-product complexes. J Cell Biol (2000) 2.26
School-based cardiovascular health promotion: the child and adolescent trial for cardiovascular health (CATCH). J Sch Health (1990) 2.23
NusG, a new Escherichia coli elongation factor involved in transcriptional antitermination by the N protein of phage lambda. J Biol Chem (1992) 2.19
RAP30/74: a general initiation factor that binds to RNA polymerase II. Mol Cell Biol (1988) 2.16
Body fatness and risk for elevated blood pressure, total cholesterol, and serum lipoprotein ratios in children and adolescents. Am J Public Health (1992) 2.16
Atherosclerosis of the aorta and coronary arteries and cardiovascular risk factors in persons aged 6 to 30 years and studied at necropsy (The Bogalusa Heart Study). Am J Cardiol (1992) 2.15
Direct interaction between the transcriptional activation domain of human p53 and the TATA box-binding protein. J Biol Chem (1993) 2.15
An unusual eukaryotic protein phosphatase required for transcription by RNA polymerase II and CTD dephosphorylation in S. cerevisiae. Mol Cell (1999) 2.14
Factors involved in specific transcription by mammalian RNA polymerase II. RNA polymerase II-associating protein 30 is an essential component of transcription factor IIF. J Biol Chem (1988) 2.12
Assembly of transcription elongation complexes containing the N protein of phage lambda and the Escherichia coli elongation factors NusA, NusB, NusG, and S10. Genes Dev (1991) 2.12
Three-year maintenance of improved diet and physical activity: the CATCH cohort. Child and Adolescent Trial for Cardiovascular Health. Arch Pediatr Adolesc Med (1999) 2.07
Species-specific interaction of the glutamine-rich activation domains of Sp1 with the TATA box-binding protein. Mol Cell Biol (1994) 2.07
Systolic Hypertension in the Elderly Program (SHEP). Part 1: Rationale and design. Hypertension (1991) 2.04
GAL4 is regulated by the RNA polymerase II holoenzyme-associated cyclin-dependent protein kinase SRB10/CDK8. Mol Cell (1999) 2.02
An elongation control particle containing the N gene transcriptional antitermination protein of bacteriophage lambda. Cell (1987) 2.00
Studies of blood pressures in children, ages 5-14 years, in a total biracial community: the Bogalusa Heart Study. Circulation (1976) 1.98
Effects of NusA protein on transcription termination in the tryptophan operon of Escherichia coli. Cell (1982) 1.96
Longitudinal patterns of cigarette smoking and smokeless tobacco use in youth: the Bogalusa Heart Study. Am J Public Health (1986) 1.96
Elongation factor NusG interacts with termination factor rho to regulate termination and antitermination of transcription. Genes Dev (1993) 1.93
A cDNA encoding RAP74, a general initiation factor for transcription by RNA polymerase II. Nature (1992) 1.89
The nusA gene protein of Escherichia coli. Its identification and a demonstration that it interacts with the gene N transcription anti-termination protein of bacteriophage lambda. J Mol Biol (1981) 1.85
Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood (1995) 1.79
Initiation of transcription by RNA polymerase II is limited by melting of the promoter DNA in the region immediately upstream of the initiation site. J Biol Chem (1994) 1.78
Recognition of boxA antiterminator RNA by the E. coli antitermination factors NusB and ribosomal protein S10. Cell (1993) 1.77
Ribosomal RNA antitermination in vitro: requirement for Nus factors and one or more unidentified cellular components. Proc Natl Acad Sci U S A (1993) 1.76
Related RNA polymerase-binding regions in human RAP30/74 and Escherichia coli sigma 70. Science (1991) 1.76
Cigarette smoking and tobacco usage behavior in children with adolescents: Bogalusa Heart Study. Prev Med (1980) 1.75
Termination of transcription by nusA gene protein of Escherichia coli. Nature (1981) 1.75
malB region in Escherichia coli K-12: specialized transducing bacteriophages and first restriction map. J Bacteriol (1978) 1.74
Relationships between relative binding affinity and electrophoretic behavior of rabbit antibodies to streptococcal carbohydrates. J Exp Med (1971) 1.72
An essential component of a C-terminal domain phosphatase that interacts with transcription factor IIF in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1997) 1.70
Surrogate endpoints in clinical trials: cardiovascular diseases. Stat Med (1989) 1.68
Utility of an automatic instrument for blood pressure measurement in children. The Bogalusa Heart Study. Am J Hypertens (1996) 1.68
Design of process evaluation within the Child and Adolescent Trial for Cardiovascular Health (CATCH). Health Educ Q (1994) 1.65
The interaction of cigarette smoking, oral contraceptive use, and cardiovascular risk factor variables in children: the Bogalusa Heart Study. Am J Public Health (1982) 1.65
Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivation. J Virol (1995) 1.63
A protein-RNA interaction network facilitates the template-independent cooperative assembly on RNA polymerase of a stable antitermination complex containing the lambda N protein. Genes Dev (1995) 1.59
Host factor requirements for processive antitermination of transcription and suppression of pausing by the N protein of bacteriophage lambda. J Biol Chem (1992) 1.56
Wrapping of promoter DNA around the RNA polymerase II initiation complex induced by TFIIF. Mol Cell (1998) 1.55
Localization of subunits of transcription factors IIE and IIF immediately upstream of the transcriptional initiation site of the adenovirus major late promoter. J Biol Chem (1996) 1.54
RAP74 induces promoter contacts by RNA polymerase II upstream and downstream of a DNA bend centered on the TATA box. Proc Natl Acad Sci U S A (1997) 1.53
Exercise-induced ischemia in mildly symptomatic patients with coronary-artery disease and preserved left ventricular function. Identification of subgroups at risk of death during medical therapy. N Engl J Med (1984) 1.51
Interaction of elongation factors TFIIS and elongin A with a human RNA polymerase II holoenzyme capable of promoter-specific initiation and responsive to transcriptional activators. J Biol Chem (1997) 1.49
Cigarette smoking attitudes and first use among third- through sixth-grade students: the Bogalusa Heart Study. Am J Public Health (1997) 1.47
National trends in the management of cardiovascular disease risk factors in children: second NHLBI survey of primary care physicians. Pediatrics (1998) 1.46
The nut site of bacteriophage lambda is made of RNA and is bound by transcription antitermination factors on the surface of RNA polymerase. Genes Dev (1991) 1.45
Risk factors in early life as predictors of adult heart disease: the Bogalusa Heart Study. Am J Med Sci (1989) 1.44
Angiogenic effects of low molecular weight heparin in patients with stable coronary artery disease: a pilot study. J Am Coll Cardiol (1993) 1.42
FCP1, the RAP74-interacting subunit of a human protein phosphatase that dephosphorylates the carboxyl-terminal domain of RNA polymerase IIO. J Biol Chem (1998) 1.42
Management of cardiovascular disease risk factors in children. A national survey of primary care physicians. Am J Dis Child (1990) 1.42
Trends in cigarette smoking among children in a southern community, 1976-1994: the Bogalusa Heart Study. Ann Epidemiol (1996) 1.41
Development trends of first cigarette smoking experience of children: the Bogalusa heart study. Am J Public Health (1982) 1.41
Direct interaction between two Escherichia coli transcription antitermination factors, NusB and ribosomal protein S10. J Mol Biol (1992) 1.39
Energy intake and physical activity in relation to indexes of body fat: the National Heart, Lung, and Blood Institute Growth and Health Study. Am J Clin Nutr (1994) 1.39
Serial long-term assessment of the natural history of asymptomatic patients with chronic aortic regurgitation and normal left ventricular systolic function. Circulation (1991) 1.39
The alpha subunit of E. coli RNA polymerase activates RNA binding by NusA. Genes Dev (2000) 1.39
A simple way to estimate the median time and compare survival distributions in analgesic trials under informative censoring. J Biopharm Stat (1999) 1.38
A cofactor, TIP30, specifically enhances HIV-1 Tat-activated transcription. Proc Natl Acad Sci U S A (1998) 1.37
RNA polymerase II-associated proteins are required for a DNA conformation change in the transcription initiation complex. Proc Natl Acad Sci U S A (1991) 1.36
Proteins that bind to RNA polymerase II are required for accurate initiation of transcription at the adenovirus 2 major late promoter. EMBO J (1986) 1.36
Physical and sedentary activity in school children grades 5-8: the Bogalusa Heart Study. Med Sci Sports Exerc (1996) 1.36
Relation of obesity to clustering of cardiovascular disease risk factors in children and young adults. The Bogalusa Heart Study. Am J Epidemiol (1987) 1.35
Anthropometric and maturation measurements of children, ages 5 to 14 years, in a biracial community--the Bogalusa Heart Study. Am J Clin Nutr (1977) 1.34
Topological localization of the human transcription factors IIA, IIB, TATA box-binding protein, and RNA polymerase II-associated protein 30 on a class II promoter. J Biol Chem (1994) 1.34
Cigarette smoking initiation and longitudinal changes in serum lipids and lipoproteins in early adulthood: the Bogalusa Heart Study. Am J Epidemiol (1986) 1.32
Statistical design of the Child and Adolescent Trial for Cardiovascular Health (CATCH): implications of cluster randomization. Control Clin Trials (1995) 1.32
L factor that is required for beta-galactosidase synthesis is the nusA gene product involved in transcription termination. Proc Natl Acad Sci U S A (1980) 1.32
Modular organization of the E2F1 activation domain and its interaction with general transcription factors TBP and TFIIH. Oncogene (1997) 1.31
Secular trends in dietary intakes and cardiovascular risk factors of 10-y-old children: the Bogalusa Heart Study (1973-1988). Am J Clin Nutr (1993) 1.31
Dietary studies and the relationship of diet to cardiovascular disease risk factor variables in 10-year-old children--The Bogalusa Heart Study. Am J Clin Nutr (1978) 1.29
Social learning effects on trial and adoption of cigarette smoking in children: The Bogalusa heart study. Prev Med (1982) 1.29
Serum cholesterol and triglyceride levels in 3,446 children from a biracial community: the Bogalusa Heart Study. Circulation (1976) 1.27
Breakfast consumption affects adequacy of total daily intake in children. J Am Diet Assoc (1993) 1.27
Indexes of obesity and comparisons with previous national survey data in 9- and 10-year-old black and white girls: the National Heart, Lung, and Blood Institute Growth and Health Study. J Pediatr (1994) 1.27
The association of LDL receptor activity, LDL cholesterol level, and clinical course in homozygous familial hypercholesterolemia. Metabolism (1985) 1.23
Activation of the murine dihydrofolate reductase promoter by E2F1. A requirement for CBP recruitment. J Biol Chem (1999) 1.23